Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003201:Computers; D004338:Drug Combinations; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D012110:Reserpine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D010919:Placebos; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine